Continuing Education
Adverse Effects Associated with Bispecific T-Cell Engagers
Best Suited For: Pharmacist, Pharmacy Technician, Nurse, Physician Assistant (PA)
CE Credits: 1 hours
Activity Description
This CE activity reviews the adverse effect profile of bispecific T-cell engager (BTCE) therapies, including common toxicities and the underlying pathophysiology driving these effects. Participants will learn to distinguish between mild and severe adverse events, apply symptom-monitoring strategies for early detection, and understand standard operating procedures for managing patients who experience BTCE-related toxicities.
CE Credit: 1 hour
Fee: This activity does not require payment to register.
Learning Objectives
- Identify common adverse effects associated with Bi-specific T-cell engager (BTCE) therapy
- Describe the pathophysiology behind adverse effects caused by BTCE
- Differentiate between mild and severe adverse effects of BTCE therapies
- Apply symptom-monitoring strategies to detect potential adverse effects early in patients receiving BTCEs
- Discuss standard operating procedures for patients experiencing adverse effects from BTCE
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted will be viewable in your CPE Monitor profile within 24 hours.
